Optic Nerve Compliance Study
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Chronic glaucoma is one of the leading causes of blindness and visual loss in the developed world. It is a condition where long term exposure to high eye pressures (intra-ocular pressure) damages the nerve fibres in the eye. This damage can be seen by examiners as changes in the optic nerve. The exact mechanism of how the high intra-ocular pressure causes nerve damage is unknown. Both physiological and mechanical mechanisms are thought to play a role. Previous authors have reported structural changes in the connective tissue of optic nerves of eyes with glaucoma. Structural changes in the optic nerve head which affect the mechanical compliance of the nerve may be significant in the cause of glaucomatous nerve damage. This study aims to assess the compliance of the optic disc in subjects with and without glaucoma. We would test compliance by imaging the optic discs of participants before and during a brief (less than two minutes) increase in intra-ocular pressure. We would aim to repeat the tests on the same subjects 3 years later to see how compliance changed. We would also seek to correlate other important parameters such as corneal thickness and visual field changes with our findings
| Condition | Intervention |
|---|---|
|
Glaucoma |
Procedure: Brief Elevation of IOP |
| Study Type: | Interventional |
| Study Design: | Allocation: Non-Randomized Endpoint Classification: Safety Study Intervention Model: Single Group Assignment Masking: Open Label |
| Official Title: | Optic Nerve Compliance Study |
- Optic Disc Change
- Visual Field Progression
- Visual Acuity Change
| Estimated Enrollment: | 100 |
| Study Start Date: | March 2006 |
| Estimated Study Completion Date: | April 2006 |
Show Detailed Description
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
Inclusion Criteria:
- Age over 18, Diagnosis of glaucoma (visual field proven), Stable, well controlled glaucoma
Exclusion Criteria:
- Previous eye surgery, Best corrected visual acuity <6/9, Chronic eye disease (including glaucoma, Secondary glaucoma (eg uveitis, neovascular glaucoma, etc), Advanced or fixation-threatening visual field changes, Ocular perfusion abnormalities (e.g. previous retinal artery or vein occlusion; or abnormal vasculature including those whose retinal circulation might be compromised by pressure on the eye).
Contacts and Locations| New Zealand | |
| Capital Vision Research Trust | |
| Wellington, New Zealand, 6001 | |
| Principal Investigator: | Anthony P Wells, FRANZCO | CVRT, Wellington School Of Medicine - University of Otago |
More Information
No publications provided by Capital Vision Research Trust
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| ClinicalTrials.gov Identifier: | NCT00328835 History of Changes |
| Other Study ID Numbers: | ONCS |
| Study First Received: | May 18, 2006 |
| Last Updated: | October 16, 2006 |
| Health Authority: | New Zealand: Health and Disability Ethics Committees |
Keywords provided by Capital Vision Research Trust:
|
Optic Nerve Glaucoma |
Additional relevant MeSH terms:
|
Glaucoma Ocular Hypertension Eye Diseases |
ClinicalTrials.gov processed this record on June 18, 2013